No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PYXS240517P5000
- 2.32
- 0.000.00%
15min DelayClose May 17 15:05 ET
2.32High0.30Low
0.75Open2.32Pre Close46 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-36.04%PremiumMay 17, 2024Expiry Date0.81Intrinsic Value100Multiplier-2DDays to Expiry1.51Time Value100Contract SizeAmericanOptions Type--Delta--Gamma1.81Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Pyxis Oncology | 10-Q: Quarterly report
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS
Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M
07:31 AM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M
Express News | Pyxis Oncology Inc - Expected Cash Runway Into 2H 2026
Express News | Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
Comments
The insider transactions at Pyxis Oncology do not provide much encouragement. However, the fact that insiders own a significant portion of the company suggests a reasonable degree of alignment with other shareholders.
Insiders Who Sold Pyxis Oncology Made The Right Call As Market Cap Slides By US$50m 1
Pyxis Oncology Announces $50 Million Private Placement: Urgent Developments in Cancer Research.
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
$Pyxis Oncology(PYXS.US$
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
$Pyxis Oncology(PYXS.US$
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
Read more